Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors
Sarah J. Horton(Wellcome/MRC Cambridge Stem Cell Institute), Brian J.P. Huntly(Wellcome/MRC Cambridge Stem Cell Institute)
Cited by 69
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
|Cell Reports|2016|834